- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A POM ad for Ilube on a journal bellyband was visible through a transparent postal wrapper. PMCPA ruled this amounted to promotion…
Two Camurus UK representatives attended a Champions League match with a UK health professional during an international congress and provided drinks afterwards.…
Anonymous ex-employee alleged an online trade-journal interview promoted unlicensed medicines to the public. Panel found PME targeted pharma executives and Indivior didn’t…
Pharmasure’s Meriofert detail aid implied superiority vs Menopur using non-inferiority studies, secondary endpoints and selective safety tables. Multiple breaches were found; one…
Complaint alleged a third-party therapy review provider linked client “product/therapy priorities” to reviews. Panel and Appeal Board had concerns about the email’s…
PMCPA found Janssen’s Janssen Response landing page breached the Code because PI links took two clicks (not single-click) and a disclaimer wrongly…
PfizerPro ‘hidden’ Useful Resources page for Sayana-Press appeared in Google results without prescribing info. Panel found it wasn’t intended for HCPs and…
Sanofi’s Dupixent website hosted a NICE guidance resource with Oct 2017 prescribing information and an HCP guide stating asthma safety/efficacy not established.…
A Pfizer UK employee ‘liked’ a Global Pfizer LinkedIn post about interim vaccine efficacy before authorisation. The Panel said this proactively disseminated…
Brintellix webinar registration page was promotional but lacked prescribing info and AE reporting statement. A global colleague changed the job code after…
Ever Pharma’s Dacepton materials were ruled misleading where stability and cost-saving claims omitted microbiological contamination caveats and key dosing context. Several other…
Two BI employees ‘liked’ a LinkedIn news post about an investigational SARS‑CoV‑2 neutralising antibody entering Phase 1/2a. Panel found the activity in…
Ex-employee alleged Allergan product specialists promoted Botox via Instagram tags/hashtags linking to HCP/clinic posts. Panel found breaches, but Appeal Board overturned due…
A Lixiana (edoxaban) print journal ad was cleared on imagery and dosing allegations, but breached the Code for failing to signpost that…
Otsuka Europe admitted it missed SOP timelines to notify affiliates of a Samsca SPC update and delayed updated prescribing information. PMCPA ruled…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.